Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Duygu Düzcan Kilimci"'
Autor:
Edanur Yeşil, Mustafa Hacımustafaoğlu, Solmaz Çelebi, Arife Özer, Duygu Düzcan Kilimci, Hale Eren, Cüneyt Özakın
Publikováno v:
Journal of Pediatric Infection. 17:20-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::018e2dd89654b937b7cbe735d24e525f
https://doi.org/10.5578/ced.20239904
https://doi.org/10.5578/ced.20239904
Autor:
Edanur Yeşil, Nilgün Köksal, Beyhan Bülbül, Demet Timur, Salih Çağrı Çakır, Mustafa Hacimustafaoglu, Beyza Ener, Melike Sezgin Evim, Betül Sevinir, Hilal Özkan, Adalet Meral Güneş, Arife Özer, Duygu Düzcan Kilimci, Solmaz Celebi, Cansu Turan
Publikováno v:
Mikrobiyoloji Bulteni. 54:120-134
Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis. The aim of this study was to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28febbe7fc94475f0a423bbb5b6a6bbc
https://doi.org/10.5578/mb.68832
https://doi.org/10.5578/mb.68832
Autor:
Edanur, Yeşil, Solmaz, Çelebi, Melike, Sezgin Evim, Arife, Özer, Cansu, Turan, Demet, Timur, Salih Çağrı, Çakır, Beyhan, Bülbül, Beyza, Ener, Adalet Meral, Güneş, Nilgün, Köksal, Hilal, Özkan, Betül, Sevinir, Duygu, Düzcan Kilimci, Mustafa, Hacımustafaoğlu
Publikováno v:
Mikrobiyoloji bulteni. 54(1)
Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis. The aim of this study was to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::75480c6b109e13a8b873ef68f5565ec1
https://pubmed.ncbi.nlm.nih.gov/32050883
https://pubmed.ncbi.nlm.nih.gov/32050883
Publikováno v:
The Turkish journal of pediatrics. 59(6)
Sahin G, Duzcan-Kilimci D, Tanyildiz HG. Epidemiological features and risks of hemangiomas. Turk J Pediatr 2017; 59: 664-669. Hemangiomas are the most common benign tumors of childhood. The known risk factors in developing hemangiomas are female gend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54ae2b7c76b3c544ac3eaff748bb7a86
https://pubmed.ncbi.nlm.nih.gov/30035398
https://pubmed.ncbi.nlm.nih.gov/30035398